Billy Loo, MD, PhD, FASTRO

Billy W. Loo Jr., MD PhD is a Professor of Radiation Oncology, a member of the Stanford Cancer Institute, of the Molecular Imaging Program at Stanford (MIPS), and of Bio-X. He is a physician-scientist Radiation Oncologist and Bioengineer who is Director of Thoracic Radiation Oncology, Co-director of Particle Therapy, and is Principal Investigator of the FLASH Sciences Lab @Stanford.

Dr. Loo's clinical specialty is precision targeted radiotherapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and proton therapy. His clinical research is in clinical trials and implementation of new treatment techniques for lung cancer, and development of new medical imaging methods for measuring organ function and predicting response to cancer treatment. He also has developed novel applications of SABR including treatment of pulmonary emphysema and cardiac arrhythmias.

The research focus of the FLASH Sciences Lab @Stanford, directed by Prof. Loo, is the development and study of extremely rapid FLASH therapy to optimize the biological therapeutic index of cancer radiotherapy, and the technological infrastructure for this basic research and its clinical translation. Prof. Loo is co-inventor of a fundamentally new approach to delivering ultra-rapid, ultra-precise cancer therapy, pluridirectional high-energy agile scanning electronic radiotherapy (PHASER), and co-leads a program to develop it into a transformative and clinically practical technology.

Prof. Loo received his MD and PhD (Bioengineering) from University of California, Davis, San Francisco, and Berkeley, and his Radiation Oncology residency training at Stanford. He is a Fellow of the American Society for Radiation Oncology (ASTRO) and of the American College of Radiology (ACR).

Disclosures:

• Employment: Stanford University:Professor:Employee
• Compensation: Mevion: Other, Compensation Payment-End Date: 6/2024
• Ownership: none
• Leadership: none